Market Overview

UPDATE: Credit Suisse Upgrades Aetna

Related AET
Wall Street Analysts Reflect On AT&T-Time Warner Ruling, Assess Implications Outside Tech, Media
Eli Lilly CEO Calls For Uniform Prices, Better Use Of Technology In Health Care
CVS Is a Massive Bargain (GuruFocus)

In a report published Thursday, Credit Suisse analyst Chris Carter upgraded Aetna (NYSE: AET) from Neutral to Outperform, raising its price target to $83.00 from $69.00.

According to the report, as an upside is seen to 2014 guidance from a continuation of muted cost trends and potential for additional CVH synergy, AET has been upgraded to Outperform.

“Moreover, while there is uncertainty associated with hc reform, our analysis around new exchange lives and Medicaid expansion gives us comfort that any potential downside risk is limited and/or manageable,” the report said. “We are raising our estimates and increasing our TP to $83 (from $69), and view discounted valuation as attractive. Aetna is our new top pick in Managed Care and the Credit Suisse Investment Policy Committee (IPC) is adding AET to the U.S. Focus List.”

Some highlights from the report included:

-Muted cost trends expected to persist. -Comfort in downside risk. -CVH deal provides upside.

AET closed Wednesday at $69.72 with shares trading up at 1.02 percent.

Latest Ratings for AET

May 2018Credit SuisseMaintainsNeutralNeutral
May 2018Cantor FitzgeraldUpgradesNeutralOverweight
Jan 2018Credit SuisseMaintainsNeutralNeutral

View More Analyst Ratings for AET
View the Latest Analyst Ratings

Posted-In: Chris Carter Credit SuisseAnalyst Color Upgrades Analyst Ratings


Related Articles (AET)

View Comments and Join the Discussion!